Explore the intense competition among generic drug companies in Korea triggered by the government’s shift to a tiered drug pricing system, impacting earlier approvals and patent challenges.
April 2021, Managing IP
ARTICLES & NEWS
Drug pricing policy in South Korea revised to ‘tiered pricing system’
